District Court Judges Differ On Staying Reverse-Payment Cases

District Court Judges Differ On Staying Reverse-Payment Cases

Federal judges in the U.S. District Court for the District of New Jersey on Oct. 23 divided over whether to grant pharmaceutical manufacturers' motions to stay cases involving reverse-payment settlements between holders of a drug patent and generic manufacturers of the those drugs pending the U.S. Supreme Court's deciding whether it will hear an appeal of a similar case (In re Effexor XR Antitrust Litigation, Nos. 11-5479, 11-5661, 11-7504, 11-6985, 11-3523, 11-3116, 11-5590, D. N.J.; In re Lamictal Direct Purchaser Antitrust Litigation, No. 12-995, D. N.J.; In re Lipitor Antitrust Litigation,  MDL No. 2332, D. N.J.).

Find full version on lexis Advance®
Access this news story on lexis.com®